Far fewer people drop out of HIV care in South Africa than previously thought

Photo by Greg Lomas / Scholars and Gentlemen / Médecins sans Frontières
Roger Pebody
Published: 20 July 2016

Previous research has considerably over-estimated the number of people living with HIV who stop attending medical facilities, the 21st International AIDS Conference (AIDS 2016) in Durban was told yesterday.

Previous estimates have been based on data from individual clinics. As a result, people who stop attending one clinic have been assumed to have dropped out of care entirely. A new analysis, based on data from across the public health sector in South Africa, shows that many people who stop attending one clinic go on to receive medical care elsewhere.

Ensuring that people living with HIV stay in medical care is vital to achieving the individual and public health benefits of HIV treatment. Retention in care is an important step on the treatment cascade. Nonetheless, especially in resource-limited settings, there are many barriers to people staying in care, including long waiting times, drug stock-outs and stigma.

Existing studies from low and middle income countries suggest that, three years after beginning HIV treatment, around 65 to 70% of people remain in care. The missing people will include both individuals who have died and individuals who have dropped out of care.

But the existing studies are based on individual clinics and may provide an incomplete picture. Some people who have stopped attending one clinic may continue care at another clinic without the move having been recorded. Others who had stopped attending return to their original clinic but are inaccurately recorded as new patients.

Matthew Fox and colleagues looked at data from the country’s National Health Laboratory Service. This is the main provider of laboratory services for public sector clinics in South Africa – data on the vast majority of patients in the country are included.

This cohort includes records for 9.2 million people, including 3.1 million who are currently taking HIV treatment and having their viral load monitored.

One limitation is that there is no wholly reliable way to link laboratory samples with individuals (unique patient identification numbers are not used). The researchers used a process of probabilistic data matching to link records which were likely to come from the same person, taking into account the first name, last name, sex, date of birth and clinic that was recorded. They think this is likely to be around 90% accurate.

The current analysis is not on the whole cohort but on the 66,865 people who began HIV treatment in 2004 or 2005. The researchers wanted to see how many were still in care from 2013 to 2015 – a person who had their CD4 cell count or viral load monitored during that period was judged to still be in care.

The researchers looked both at retention within their original clinic and retention within the national programme.

Nine years after beginning therapy, just 17% were still attending their original clinic. However 54% were still in care somewhere in the health system.

 

1 year

5 years

9 years

Clinic retention

79%

37%

17%

System-wide retention

90%

72%

54%

Of note, the people who were not retained in care include individuals who have died as well as people who stopped attending care. In line with this, retention was poorer for people who began treatment with a low CD4 cell count and older people.

Women were more likely to still be in care than men.

It’s also worth noting that an individual who attended care both in 2004 and 2014 (and so considered ‘retained in care’ in this study) may well have had gaps in care in between those two dates.

Nonetheless the study does show that patient migration and transfer are common in South Africa. Previous studies, based on individual clinics, are likely to have considerably under-estimated retention in care.

Reference

Fox M et al. Is retention on ART underestimated due to patient transfers? Estimating system-wide retention using a national labs database in South Africa. 21st International AIDS Conference, Durban, abstract TUAB0205, 2016.

View the abstract on the conference website.

Download the presentation slides from the conference website.

Watch the webcast of this presentation on YouTube.



E-atlas

South Africa

Find details of HIV services in South Africa, the latest news from the country, and a selection of resources from local organisations.

Find out more about South Africa >

NAM’s news coverage of the International AIDS Conference has been made possible thanks to support from Merck & Co. NAM's wider conference news reporting services have been supported by Gilead, Janssen and ViiV Healthcare.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.